Livopigen ApS: Financial statements 2020
CVR: 37491659
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Livopigen ApS (CVR 37491659) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,148,683 and a net result of DKK -17,924 compared with DKK 64,840 the year before. That is a decrease of 3% compared with the year before. Equity in the 2020 report amounted to DKK 31,588. The solvency ratio was 1.5%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,148,683
- Profit/Loss
- DKK -17,924
- Equity
- DKK 31,588
- Total Assets
- DKK 2,072,119
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1.1 mio. | -18 t. | 32 t. | 2 |
| 2019 | - | 1.2 mio. | 65 t. | 50 t. | 2 |
| 2018 | - | 908 t. | 28 t. | -15 t. | 2 |
| 2017 | - | 539 t. | 227 t. | -43 t. | 2 |
| 2016 | - | 223 t. | -183 t. | -180 t. | 2 |
Official annual report
How creditworthy is Livopigen ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
On November 9, 2020, the company changed its name from Genopliv IVS to Genopliv ApS.
Livopigen ApS has published its annual report for 2019. Gross profit came to DKK 1,183,747, and the net result was DKK 64,840.
About Livopigen ApS
Livopigen ApS was a Danish company of the type Anpartsselskab based in Holbæk, founded in 2016. The company has been dissolved on 11 October 2023. The company was registered under the industry Detailhandel med medicin og produkter til personlig pleje via internet. The company was previously named Genopliv ApS and Genopliv IVS. The company has 2 employees (2022). In 2021, the company reported a gross profit of DKK 1,022,287 and a net result of DKK 42,829 compared with DKK -17,924 the year before. Equity in the 2021 report amounted to DKK 74,417.